newsfilter
← Interviews
80,000 Hours1h 37m

The science that could keep us healthy in our 80s and beyond | Laura Deming

Laura Deming, Luisa Rodriguez

Interview

Laura Deming reports on the FDA's unprecedented acceptance of efficacy data for a dog lifespan extension drug, marking the first regulatory validation of aging as a treatable indication. Supported by empirical evidence showing that genetic, drug, and cellular interventions can significantly extend life in model organisms, Deming outlines a future trajectory where increased human agency allows individuals over 50 to reverse physical decline and pursue extended careers. While acknowledging significant bottlenecks in talent, data access, and clinical trial design, she argues that these scientific challenges should not deter progress toward shifting societal views of aging from an inevitable fate to a manageable biological process.